Pikale Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 19-12-2024
- Paid Up Capital ₹ 0.10 M
as on 19-12-2024
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.79 M
as on 19-12-2024
- Satisfied Charges ₹ 4.36 M
as on 19-12-2024
- Revenue -6.89%
(FY 2023)
- Profit -98.86%
(FY 2023)
- Ebitda 72.52%
(FY 2023)
- Net Worth 0.04%
(FY 2023)
- Total Assets -0.50%
(FY 2023)
About Pikale Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.79 M. The company has closed loans amounting to ₹4.36 M, as per Ministry of Corporate Affairs (MCA) records.
Hemant Pikale and Sangeeta Pikale serve as directors at the Company.
- CIN/LLPIN
U85110MH2004PTC145680
- Company No.
145680
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Apr 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pikale Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sangeeta Pikale  | Director | 15-Apr-2004 | Current |
| Hemant Pikale | Director | 15-Apr-2004 | Current |
Financial Performance of Pikale Healthcare.
Pikale Healthcare Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.89% decrease. The company also saw a substantial fall in profitability, with a 98.86% decrease in profit. The company's net worth moved up by a moderate rise of 0.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pikale Healthcare?
Unlock access to Pikale Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Ge Capital Services India Creation Date: 18 Jun 2008 | ₹0.79 M | Open |
The Saraswat Co-Op Bank Ltd Creation Date: 02 Jul 2014 | ₹1.14 M | Satisfied |
The Saraswat Co-Op Bank Ltd Creation Date: 25 Feb 2014 | ₹1.56 M | Satisfied |
How Many Employees Work at Pikale Healthcare?
Unlock and access historical data on people associated with Pikale Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pikale Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pikale Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
